New Kind of Compound Shows Early Promise Against Prostate Cancer
A new type of molecule blocks the action of genes that drive the growth of therapy-resistant prostate cancer, according to the new study
A new type of molecule blocks the action of genes that drive the growth of therapy-resistant prostate cancer, according to the new study
Three prominent medical societies today issued a new clinical guideline for physicians treating men with early-stage prostate cancer using external beam radiation therapy (EBRT). Adoption of the guideline could make treatment shorter and more convenient for many patients with prostate cancer, the most common malignancy among American men
The biological differences between women and men go beyond basic anatomy. Researchers must consider sex differences down to the cellular level in order to discover crucial information about the varied development, function, and biology between women and men
Overactive bladder (OAB) is a common form of urinary incontinence that is widely treated with pelvic floor muscle (PFM) training. A new laboratory study lends insights into how PFM training works: by reducing contractions of the detrusor muscle of the bladder, reports the American Journal of Physical Medicine & Rehabilitation, the official journal of the Association of Academic Physiatrists
Cancer treatment is associated with a clinically meaningful survival benefit in older, medically complex patients with superficial bladder cancer (SBC), according to a study published online Oct. 5 in Cancer
A new study led by investigators at Brigham and Women's Hospital and Harvard THR Chan School of Public Health is the first to look at the results of the black men and to whether an optimized screening strategy with baseline prostate-specific antigen (PSA) levels predict prostate cancer in this population
Scientists have shown that cellulose serves a mortar-like role to enhance the adhesion of bacteria to bladder cells, causing urinary tract infections. Stanford researchers have shown that bacteria involved in urinary tract infections (UTI) rely on a novel chemical form of the molecule cellulose to stick to bladder cells. The finding, published in the journal of the PNAS could lead to new ways of treating UTIs and other infections without antibiotics.
Routine testing for prostate cancer is not recommended for most men because the benefit is small and uncertain and there are clear harms, say a panel of international experts in The BMJ today
Scientists have discovered a link between certain genetic mutations, the aggressiveness of prostate cancer, risk of developing the disease and poorer survival rates of patients. The gene, called ANO7, could play a vital role in improving diagnosis of prostate cancer patients. There are over 50,000 new cases and 11,000 deaths from prostate cancer each year in the U.K
Men who suffer from urological problems such as erectile dysfunction, urinary tract and bladder problems or infertility issues often also suffer from depression and sleep disorders
Moffitt Cancer Center researchers examined data from more than 800 surgical patients with advanced bladder cancer. The results, published online by JAMA Oncology, show higher likelihoods of complete response or down-staging associated with a chemotherapeutic combination called ddMVAC
"Invasive and uncomfortable' procedures for detecting if someone has bladder cancer could be replaced by urine tests that not only screen for the presence of the disease but also help doctors choose the right course of treatment for a particular patient